Standard-dose versus double-dose dolutegravir in HIV-associated tuberculosis in South Africa (RADIANT-TB): a phase 2, non-comparative, randomised controlled trial by Griesel, R, Zhao, Y, Simmons, B, Omar, Z, Wiesner, L, Keene, CM, Hill, AM, Meintjes, G, Maartens, G

Moderate to severe HIV-associated neurocognitive impairment: A randomized placebo-controlled trial of lithium by Decloedt, E, Freeman, C, Howells, F, Casson-Crook, M, Lesosky, M, Koutsilieri, E, Lovestone, S, Maartens, G, Joska, J

Initial supplementary dose of dolutegravir in second-line antiretroviral therapy: a noncomparative, double-blind, randomized placebo-controlled trial by Zhao, Y, Griesel, R, Omar, Z, Simmons, B, Hill, A, van Zyl, G, Keene, C, Maartens, G, Meintjes, G

Recycling tenofovir in second-line antiretroviral treatment with dolutegravir: outcomes and viral load trajectories to 72 weeks by Keene, CM, Cassidy, T, Zhao, Y, Griesel, R, Jackson, A, Sayed, K, Omar, Z, Hill, A, Ngwenya, O, Van Zyl, G, Flowers, T, Goemaere, E, Maartens, G, Meintjes, G

AntiRetroviral Therapy In Second-line: investigating Tenofovir-lamivudine-dolutegravir (ARTIST): protocol for a randomised controlled trial by Zhao, Y, Keene, C, Griesel, R, Sayed, K, Gcwabe, Z, Jackson, A, Ngwenya, O, Schutz, C, Goliath, R, Cassidy, T, Goemaere, E, Hill, A, Maartens, G, Meintjes, G

Impact of dolutegravir-based antiretroviral therapy on piperaquine exposure following dihydroartemisinin-piperaquine intermittent preventive treatment of malaria in pregnant women... by Banda, CG, Nkosi, D, Allen, E, Workman, L, Madanitsa, M, Chirwa, M, Kapulula, M, Muyaya, S, Munharo, S, Tarning, J, Phiri, KS, Mwapasa, V, ter Kuile, FO, Maartens, G, Barnes, KI

Isoniazid preventive therapy added to ART to prevent TB: an individual participant data meta-analysis by Ross, J, Badje, A, Rangaka, M, Walker, AS, Shapiro, A, Thomas, K, Anglaret, X, Eholie, S, Gabillard, D, Boulle, A, Maartens, G, Wilkinson, RJ, Ford, N, Golub, J, Williams, B, Barnabas, R

Virologic efficacy of tenofovir, lamivudine and dolutegravir as second-line antiretroviral therapy in adults failing a tenofovir-based first-line regimen by Keene, CM, Griesel, R, Zhao, Y, Gcwabe, Z, Sayed, K, Hill, A, Cassidy, T, Ngwenya, O, Jackson, A, van Zyl, G, Schutz, C, Goliath, R, Flowers, T, Goemaere, E, Wiesner, L, Simmons, B, Maartens, G, Meintjes, G

Mycobacterium tuberculosis bloodstream infection prevalence, diagnosis, and mortality risk in seriously ill adults with HIV: a systematic review and meta-analysis of individual pat... by Barr, DA, Lewis, JM, Feasey, N, Schutz, C, Kerkhoff, AD, Jacob, ST, Andrews, B, Kelly, P, Lakhi, S, Muchemwa, L, Bacha, HA, Hadad, DJ, Bedell, R, van Lettow, M, Zachariah, R, Crump, JA, Alland, D, Corbett, EL, Gopinath, K, Singh, S, Griesel, R, Maartens, G, Mendelson, M, Ward, AM, Parry, CM, Talbot, EA, Munseri, P, Dorman, SE, Martinson, N, Shah, M, Cain, K, Heilig, CM, Varma, JK, von Gottberg, A, Sacks, L, Wilson, D, Squire, SB, Lalloo, DG, Davies, G, Meintjes, G